News
Edwards Lifesciences is projected to deliver steady profit and revenue growth through 2026. Click here to read more on EW ...
This was the stock's fourth consecutive day of gains.
This was the stock's second consecutive day of gains.
Edwards Lifesciences (EW) stock and Medtronic (MDT) stock gain as Boston Scientific (BSX) halts sales of ACURATE heart valves ...
Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.
Edwards Lifesciences EW has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Investors responded positively to the news, boosting Edwards Lifesciences’ stock during the trading session. The company, which is a leading player in the heart valve market, may now face less ...
2d
Investor's Business Daily on MSNEdwards Lifesciences Getting Closer To Key Technical MeasureA Relative Strength Rating upgrade for Edwards Lifesciences shows improving technical performance. Will it continue?
Bill Baruch, founder & president at Blue Line Capital, joins CNBC’s 'Halftime Report' to detail his latest buy.
8d
Medical Device Network on MSNEdwards’ study demonstrates value in early aortic stenosis interventionNew research by Edwards Lifesciences has demonstrated that early intervention for severe aortic stenosis (AS) before symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results